Henk A. Solleveld, D.V.M, Ph.D. Co-Founder & Consultant, HEN-MAR
Henk has been a successful and productive leader across pharmaceutical R&D for over 20 years. Among his many accomplishments has been management of many programs/projects within both Safety Assessment and Discovery across a range of therapeutic areas. He was involved in the filing of 7 NDAs and many more INDs.
Most recently Henk was Transnational Vice-President and Head of Preclinical Drug Discovery in the Cardiovascular-Urology Center of Excellence for Drug Discovery (CVU CEDD) with staff in US, UK and France (2000-2008). Prior to the formation of GSK, Henk was Transnational Group Director of Pathology and Regulatory Toxicology in the Safety Assessment Department of SmithKline Beecham (SB) with operations in the US and UK.
Henk earned both his Doctor of Veterinary Medicine (cum laude) and his PhD (cum laude) degrees from the State University of Utrecht, Utrecht, The Netherlands. He is board certified (Dutch registry) in laboratory animal pathology and veterinary pathology and has widely published (about 130 manuscripts, book chapters and abstracts) in the areas of pathology and toxicology.
